Completion axillary lymph node dissection for breast cancer: Immediate versus delayed versus none

Journal of Clinical Oncology

Volumn 26, Issue 21, 2008, Pages 3483-3484

  Bear, Harry D ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER STAGING; EDITORIAL; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MICROMETASTASIS; MORBIDITY; PEROPERATIVE CARE; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; AXILLA; BREAST TUMOR; CLINICAL TRIAL; FEMALE; LYMPHADENECTOMY; NOTE; TIME;

AXILLA; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; LYMPH NODE EXCISION; TIME;

EID: 49049118293     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.17.1751     Document Type: Editorial

References (25)

1. Lyman GH, Giuliano AE, Somerfield MR, et al: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703-7720, 2005
2. Krag DN, Anderson SJ, Julian TB, et al: Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: Results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881-888, 2007
3. Veronesi U, Paganelli G, Viale G, et al: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546-553, 2003
4. Mansel RE, Fallowfield L, Kissin M, et al: Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. J Natl Cancer Inst 98:599-609, 2006
5. Kelley MC, Hansen N, McMasters KM: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg 188:49-61, 2004
6. Wilke LG, McCall LM, Posther KE, et al: Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial. Ann Surg Oncol 13:491-500, 2006
7. Fleissig A, Fallowfield LJ, Langridge CI, et al: Post-operative arm morbidity and quality of life: Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95:279-293, 2006
8. Lucci A, McCall LM, Beitsch PD, et al: Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group trial Z0011. J Clin Oncol 25:3657-3663, 2007
9. Kim T, Giuliano AE, Lyman GH: Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: A meta-analysis. Cancer 106:4-16, 2006
10. Grube BJ, Giuliano AE: Observation of the breast cancer patient with a tumor-positive sentinel node: Implications of the ACOSOG Z0011 trial. Semin Surg Oncol 20:230-237, 2001
11. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140-1151, 2003
12. Julian TB, Anderson SJ, Fourchotte V, et al: Is completion axillary dissection always required after a positive sentinel node biopsy? NSABP B-32. Breast Cancer Res Treat 106:S15, 2007 (abstr 51)
13. Rutgers EJ: Sentinel node biopsy: Interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases. J Clin Oncol 26:698-702, 2008
14. Houvenaeghel G, Nos C, Mignotte H, et al: Micrometastases in sentinel lymph node in a multicentric study: Predictive factors of non-sentinel lymph node involvement. J Clin Oncol 24:1814-1822, 2006
15. Olson JA, McCall LM, Beitsch P, et al: Impact of immediate vs. delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: Results from the American College of Surgeons Oncology Group (ACOSOG) trials Z0010 and Z0011. J Clin Oncol 26:3530-3535, 2008
16. Treseler P: Pathologic examination of the sentinel lymph node: What is the best method? Breast J 12:S143-S151, 2006
17. Forbes RC, Pitchford C, Simpson JF, et al: Selective use of intraoperative touch prep analysis of sentinel nodes in breast cancer. Am Surg 71:955-960, 2005
18. Tew K, Irwig L, Matthews A, et al: Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg 92:1068-1080, 2005
19. Mori M, Tada K, Ikenaga M, et al: Frozen section is superior to imprint cytology for the intra-operative assessment of sentinel lymph node metastasis in stage I breast cancer patients. World J Surg Oncol 4:26-29, 2006
20. Chan SW, LaVigne KA, Port ER, et al: Does the benefit of sentinel node frozen section vary between patients with invasive duct, invasive lobular, and favorable histologic subtypes of breast cancer? Ann Surg 247:143-149, 2008
21. Rivers A, Hansen N: Axillary management after sentinel lymph node biopsy in breast cancer patients. Surg Clin North Am 87:365-377, ix, 2007
22. Viale G, Maiorano E, Pruneri G, et al: Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 241:319-325, 2005
23. Katz A, Niemierko A, Gage I, et al: Can axillary dissection be avoided in patients with sentinel lymph node metastasis? J Surg Oncol 93:550-558, 2006
24. Julian TB, Fourchotte V, Anderson S, et al: Predictive factors for which a breast cancer sentinel lymph node biopsy can be avoided. Ann Surg Oncol 15:16, 2008 (abstr 48)
25. Blumencranz P, Whitworth PW, Deck K, et al: Sentinel node staging for breast cancer: Intraoperative molecular pathology overcomes conventional histologic sampling errors. Am J Surg 194:426-432, 2007